immunology

UT Southwestern Scientists Discover Infection-Fighting ‘Timekeeper’ for Body’s Immune Cells

by | Sep 11, 2025
The discovery reveals why people may be more susceptible to infections at certain times of day—and could open new paths for cancer immunotherapy and infection treatments.
MORE
CAGE Bio Relocates Fort Worth Office to BioLabs at Pegasus Park in Dallas
by | Jul 15, 2025
The California-based clinical-stage biotech startup is developing therapies to treat serious immunological diseases like atopic dermatitis and vitiligo.
MORE
UT Southwestern Maps a Cancer-Enabling Protein That Lets B-Cell Tumors Hang On—With a Nobel Laureate on the Case
by | Jun 16, 2025
The protein—implicated in blood cancers like leukemia, lymphoma, and multiple myeloma—was decoded in near-atomic detail by UT Southwestern researchers, including Nobel Prize winner Bruce Beutler. In lab models, turning off midnolin wiped out up to 92% of cancer cells—with minimal impact on healthy ones, according to UT Southwestern.
MORE
Dallas’ AllerVie Clinical Research Appoints Chief Research Innovation Officer
by | May 5, 2023
Formerly AllerVie’s chief medical officer, Dr. Weily Soong will lead efforts to drive innovation with new therapies and diagnostics for asthma, allergies, and other related immunological conditions at AllerVie Clinical Research.
MORE

Southlake BioTech Startup Gets $10M Grant from CPRIT for Technology That ‘Lights Up’ Cancer

by | Aug 20, 2020
OncoNano Medicine, a spinout of University of Texas Southwestern, uses pH as a biomarker to detect metastatic cancer. Its technology, which visualizes a tumor, could be a gamechanger.
MORE
Clinical-Stage Biotech Expands From Silicon Valley to the University of North Texas Health Science Center in Fort Worth
by | Jul 13, 2020
CAGE Bio—currently a resident at Johnson & Johnson Innovation—uses a proprietary platform to develop therapeutic products for dermatology, inflammation, and immunology.
MORE